Search Vehicles

Biologics Manufacturing And Nonclinical Services

IDIQ

Description

Provide support for both Biologics current good manufacturing practices (cGMP) manufacturing and GLP nonclinical services, including execution of the studies and completing study reports and documentation that will enable regulatory filing and evaluation of biological therapeutics in clinical trials for NIH drug development programs. The vehicle supports the NIH biologics development projects for the NIH Blueprint Neurotherapeutics Network Biologics (BPN-Biologics) program, the NINDS Ultra-Rare Gene Therapy (URGenT) program, the Helping to End Addiction Long-term Pain Therapeutics Development Program (HEAL-PTDP), as well as other extramural or intramural NIH drug discovery and development programs.

Show All

Overview

Ceiling
$149,200,000
Primary Sponsoring Agency
National Institute on Drug Abuse (NIDA) [HHS - NIH]
Who Can Use
One Agency
Primary NAICS
541512 - Computer Systems Design Services
Primary PSC
AN12 - Health R&D Services; Health Care Services; Applied Research
Primary Set Aside
None
Extent Competed
Full And Open Competition
Related Opportunity
Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products (Biologics) for Neurological-related Disorders (75N95022R00013)
Biologics Manufacturing And Nonclinical Services awarded by National Institute on Drug Abuse (NIDA) in September 2022 accepts orders through September 2030. The IDIQ has a reported ceiling of $149,200,000, and as of today, $26,163,477 has been obligated through the vehicle with a total reported backlog of $28,231,723. The IDIQ was awarded full & open and has a primary NAICS code of 541512.

Award Hierarchy

Vehicle

Biologics Manufacturing And Nonclinical Services

Indefinite Delivery Vehicles

-

Prime Contracts

-

Subcontracts

-

Status

Period of Performance

9/28/22

Start Date

9/29/30

Ordering Period End Date
35.0% Complete

Task Order Obligations and Backlog

$26.2M

Total Obligated

$26.2M

Current Award

$54.4M

Potential Award
48% Funded

$0.0

Funded Backlog

$28.2M

Total Backlog
Vehicle Award Share

Contractors with greatest percentage of obligations for Biologics Manufacturing And Nonclinical Services

Radar chart of market share on Biologics Manufacturing And Nonclinical Services

Vehicle Award Share

Federal Award Analysis

Biologics Manufacturing And Nonclinical Services contract spending

$-

Contracts

$-

Subcontracts

$-

Grants

$-

Subgrants

$-

Total

Interactive Stacked Bar Chart


No Results
Calculating


No Results
Calculating


No Results
Calculating
Year Contracts Subcontracts Grants Subgrants


No Results
Calculating


No Results
Calculating


No Results
Calculating


No Results
Calculating


No Results
Calculating

Awardees

Biologics Manufacturing And Nonclinical Services awardees
Contract Awards

Biologics Manufacturing And Nonclinical Services task orders
Subcontract Awards

Biologics Manufacturing And Nonclinical Services subcontracts